AGX-901
- Generic Name
- AGX-901
A Study to Assess the Safety of ARGX-109 in Healthy Volunteers
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- argenx
- Target Recruit Count
- 32
- Registration Number
- NCT06799416
- Locations
- 🇨🇦
Altasciences - Montreal - Phase I unit, Mount-Royal, Quebec, Canada
Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis
Phase 2
Withdrawn
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2018-07-11
- Lead Sponsor
- Bird Rock Bio, Inc.
- Registration Number
- NCT02795299
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath